Outcome of tacrolimus and vedolizumab after corticosteroid and anti-TNF failure in paediatric severe colitis

BACKGROUND: Severe colitis flare from ulcerative colitis (UC) or Crohn’s disease (CD) may be refractory to corticosteroids and antitumour necrosis factor (TNF) agents resulting in high colectomy rates. We aimed to describe the utility of tacrolimus to prevent colectomy during second-line vedolizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamel, Blaise, Wu, May, Hamel, Elizabeth O, Bass, Dorsey M, Park, K T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841492/
https://www.ncbi.nlm.nih.gov/pubmed/29527316
http://dx.doi.org/10.1136/bmjgast-2017-000195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841492/
https://www.ncbi.nlm.nih.gov/pubmed/29527316
http://dx.doi.org/10.1136/bmjgast-2017-000195

Ejemplares similares